BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 25381647)

  • 1. Savings in Medical Expenditures Associated with Reductions in Body Mass Index Among US Adults with Obesity, by Diabetes Status.
    Cawley J; Meyerhoefer C; Biener A; Hammer M; Wintfeld N
    Pharmacoeconomics; 2015 Jul; 33(7):707-22. PubMed ID: 25381647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Burden of Obesity on Diabetes in the United States: Medical Expenditure Panel Survey, 2008 to 2012.
    Leung MY; Carlsson NP; Colditz GA; Chang SH
    Value Health; 2017 Jan; 20(1):77-84. PubMed ID: 28212973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of body mass index with health care expenditures in the United States by age and sex.
    Ward ZJ; Bleich SN; Long MW; Gortmaker SL
    PLoS One; 2021; 16(3):e0247307. PubMed ID: 33760880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of body mass index on prescribing costs and potential cost savings of a weight management programme in primary care.
    Counterweight Project Team
    J Health Serv Res Policy; 2008 Jul; 13(3):158-66. PubMed ID: 18573765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of morbid obesity on medical expenditures in adults.
    Arterburn DE; Maciejewski ML; Tsevat J
    Int J Obes (Lond); 2005 Mar; 29(3):334-9. PubMed ID: 15685247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of body mass index in young adulthood and middle age to Medicare expenditures in older age.
    Daviglus ML; Liu K; Yan LL; Pirzada A; Manheim L; Manning W; Garside DB; Wang R; Dyer AR; Greenland P; Stamler J
    JAMA; 2004 Dec; 292(22):2743-9. PubMed ID: 15585734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity and expenditures among elderly Veterans Health Administration users with diabetes.
    Shen Y; Sambamoorthi U; Rajan M; Miller D; Banerjea R; Pogach L
    Popul Health Manag; 2009 Oct; 12(5):255-64. PubMed ID: 19848567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of obesity on health service utilization and costs in childhood.
    Trasande L; Chatterjee S
    Obesity (Silver Spring); 2009 Sep; 17(9):1749-54. PubMed ID: 19300433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimates of the direct and indirect cost savings associated with heart disease that could be avoided through dietary change in the United States.
    Cawley J; Meyerhoefer C; Gillingham LG; Kris-Etherton P; Jones PJ
    J Med Econ; 2017 Feb; 20(2):182-192. PubMed ID: 27724055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical services utilization and expenditure of obesity-related disorders in Taiwanese adults.
    Chu NF; Wang SC; Chang HY; Wu DM
    Value Health; 2010; 13(6):829-36. PubMed ID: 20825625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The medical cost of cardiometabolic risk factor clusters in the United States.
    Sullivan PW; Ghushchyan V; Wyatt HR; Hill JO
    Obesity (Silver Spring); 2007 Dec; 15(12):3150-8. PubMed ID: 18198326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healthcare costs and obesity prevention: drug costs and other sector-specific consequences.
    Rappange DR; Brouwer WB; Hoogenveen RT; Van Baal PH
    Pharmacoeconomics; 2009; 27(12):1031-44. PubMed ID: 19908927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Out-of-pocket health care expenditures due to excess of body weight in Portugal.
    Veiga P
    Econ Hum Biol; 2008 Mar; 6(1):127-42. PubMed ID: 17921075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity and health expenditures: evidence from Australia.
    Buchmueller TC; Johar M
    Econ Hum Biol; 2015 Apr; 17():42-58. PubMed ID: 25637887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The costs of obesity in the workplace.
    Finkelstein EA; DiBonaventura Md; Burgess SM; Hale BC
    J Occup Environ Med; 2010 Oct; 52(10):971-6. PubMed ID: 20881629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct medical costs of obesity in the United States and the most populous states.
    Cawley J; Biener A; Meyerhoefer C; Ding Y; Zvenyach T; Smolarz BG; Ramasamy A
    J Manag Care Spec Pharm; 2021 Mar; 27(3):354-366. PubMed ID: 33470881
    [No Abstract]   [Full Text] [Related]  

  • 17. A health economic model to assess the cost-effectiveness of OPTIFAST for the treatment of obesity in the United States.
    Nuijten M; Marczewska A; Araujo Torres K; Rasouli B; Perugini M
    J Med Econ; 2018 Sep; 21(9):835-844. PubMed ID: 29678127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic Evaluation of the effect of Quitting Smoking on Weight Gains: Evidence from the United Kingdom.
    Pieroni L; Minelli L; Salmasi L
    Value Health; 2015 Sep; 18(6):791-9. PubMed ID: 26409606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costs associated with depression and obesity among cardiovascular patients: medical expenditure panel survey analysis.
    Tápias FS; Otani VHO; Vasques DAC; Otani TZS; Uchida RR
    BMC Health Serv Res; 2021 May; 21(1):433. PubMed ID: 33957919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health care expenditures associated with overweight and obesity among US adults: importance of age and race.
    Wee CC; Phillips RS; Legedza AT; Davis RB; Soukup JR; Colditz GA; Hamel MB
    Am J Public Health; 2005 Jan; 95(1):159-65. PubMed ID: 15623877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.